Back

Glycemic control with canagliflozin, a SGLT-2 inhibitor, attenuates atherosclerosis and endothelial dysfunction in diabetic apolipoprotein e-deficient mice

31 August 2019 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Lipids and metabolism Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Arief Rahadian

Dian Nuswantoro University, Semarang (Indonesia)

11 More presentations in this session

Presentation thumbnail
Doctor J. Jehle (Bonn, DE)
Abstract
Presentation thumbnail
Mr I. Melnikov (Moscow, RU)
Abstract Slides
Presentation thumbnail
Doctor K. Pahk (Seoul, KR)
Abstract
Presentation thumbnail
Doctor A. Taheri (Zurich, CH)
Abstract
Presentation thumbnail
Doctor R. Durst (Jerusalem, IL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Lipids and metabolism

The Event

Event poster

ESC Congress 2019

31 August 2019 11:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources